Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistanceAnti-Cancer Drugs, 2018, 29 (8), pp.748-755. ⟨10.1097/CAD.0000000000000647⟩
Journal articles
inserm-02402025v1
|